<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Case Studies 07-15: Additional Case Studies (Abbreviated) - Stock Trading Mastery</title>
    <link rel="stylesheet" href="../css/style.css">
    <link rel="icon" type="image/svg+xml" href="data:image/svg+xml,<svg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 100 100'><text y='75' font-size='75' fill='%230066cc'>üìà</text></svg>">
</head>
<body>
    <header>
        <div class="header-content">
            <a href="../index.html" class="logo">üìà Stock Trading Mastery</a>
            <div class="nav-controls">
                <div class="search-box">
                    <input type="text" id="searchInput" placeholder="Search lessons..." class="tab-focus">
                </div>
                <button id="darkModeToggle" class="theme-toggle tab-focus">üåô Dark Mode</button>
                <button id="menuToggle" class="menu-toggle tab-focus">‚ò∞ Menu</button>
            </div>
        </div>
    </header>

    <div class="container">
        <aside id="sidebar" class="sidebar">
            <div class="nav-section">
                <div class="nav-section-title">Navigation</div>
                <a href="../index.html" class="nav-item">Home</a>
                <a href="course-overview.html" class="nav-item">Course Overview</a>
            </div>
        </aside>

        <main class="main-content">
            <div class="progress-section">
                <div class="progress-header">Your Progress</div>
                <div class="progress-bar-container">
                    <div class="progress-bar" style="width: 0%"></div>
                </div>
                <div class="progress-text">0 / 133 lessons completed (0%)</div>
            </div>

            <div class="breadcrumb"><a href="../index.html">Home</a> <span>/</span> <span>Chapter 0</span> <span>/</span> <span>Case Studies 07-15: Additional Case Studies (Abbreviated)</span></div>

            <article class="lesson-content">
                <div class="lesson-header">
                    <h1 class="lesson-title">Case Studies 07-15: Additional Case Studies (Abbreviated)</h1>
                    <div class="lesson-meta">
                        <div class="lesson-meta-item">
                            <span>Chapter 0</span>
                        </div>
                    </div>
                </div>

                <h1>Case Studies 07-15: Additional Case Studies (Abbreviated)</h1>
<hr>
<h2>Case Study 07: Sector Rotation Success - AI to Energy to Semiconductors</h2>
<p><strong>Duration</strong>: 6 months (Q1 - Q2 2023)</p>
<p><strong>Strategy</strong>: Rotating between outperforming sectors based on economic indicators</p>
<p><strong>Performance</strong>: +48% vs +8% for S&P 500</p>
<p><strong>Key Insight</strong>: Sector momentum exists and can be traded systematically</p>
<h3>The Strategy</h3>
<ul>
<li>January 2023: 100% in Energy (XLE) - Oil rally expected</li>
<li>March 2023: Rotate to Semiconductors (SMH) - AI boom beginning</li>
<li>May 2023: Rotate to Consumer Staples - Economic slowdown expected</li>
</ul>
<h3>Results by Quarter</h3>
<ul>
<li>Q1: Energy +35% (won)</li>
<li>Q2: Semiconductors +28% (won)</li>
<li>Full period: +48% return</li>
</ul>
<h3>Key Lessons</h3>
<ol>
<li>Sector rotation can beat stock picking</li>
<li>Follow leading economic indicators (rates, inflation, unemployment)</li>
<li>Take profits when sector extended</li>
<li>Have clear rotation criteria before entering</li>
</ol>
<h3>When It Fails</h3>
<ul>
<li>Whipsaws between sectors</li>
<li>Rotation signals are late</li>
<li>Emotional attachment to winning sectors</li>
<li>Transaction costs eat profits</li>
</ul>
<hr>
<h2>Case Study 08: Holding Through Liquidation - The Theranos Story</h2>
<p><strong>Duration</strong>: 18 months (Partial hold through collapse)</p>
<p><strong>Initial Position</strong>: $15,000 in Theranos (THNO)</p>
<p><strong>Outcome</strong>: -80% loss on $15,000 = -$12,000</p>
<p><strong>Exit</strong>: Should have exited at -40%, held to -80%</p>
<p><strong>Key Lesson</strong>: Management fraud is hard to detect until it's too late</p>
<h3>The Timeline</h3>
<ul>
<li>Month 1-3: Up 15% - "I'm a genius investor"</li>
<li>Month 4-6: Down 20% - "Temporary dip, hold"</li>
<li>Month 9-12: Down 60% - "It's a value now"</li>
<li>Month 12-18: Down 80% - Bankruptcy</li>
<li>Reality: SEC fraud investigation revealed Theranos fraudulent</li>
</ul>
<h3>What Went Wrong</h3>
<ol>
<li>No management track record verification</li>
<li>No independent verification of claims</li>
<li>Held through clear warning signs</li>
<li>Confused "cheap" with "good value"</li>
</ol>
<h3>The Lesson</h3>
<ul>
<li>Real companies have audited financials</li>
<li>Real companies have public track records</li>
<li>If you can't explain the business, don't invest</li>
<li>Bankruptcy is a real risk (not theoretical)</li>
</ul>
<hr>
<h2>Case Study 09: The Penny Stock Trap - Pump and Dump Cycle</h2>
<p><strong>Duration</strong>: 2 months (Rapid rise and collapse)</p>
<p><strong>Stock</strong>: A $2 biotechnology startup (fictitious)</p>
<p><strong>Entry</strong>: $0.80/share (1,000 shares = $800)</p>
<p><strong>Peak</strong>: $3.20 (up 300%) in week 6</p>
<p><strong>Exit</strong>: $0.15 (down 95%) in week 8</p>
<p><strong>Result</strong>: Turn $800 into $150 (lost $650 = -81%)</p>
<h3>The Pattern</h3>
<ol>
<li><strong>Accumulation</strong>: Insiders and friends buy quietly at $0.20</li>
<li><strong>The Pump</strong>: Announcement of "breakthrough research" or FDA approval</li>
<li><strong>FOMO</strong>: Retail traders pile in, stock rises to $3.20</li>
<li><strong>The Dump</strong>: Insiders sell all shares they accumulated at $0.20</li>
<li><strong>Collapse</strong>: Stock falls back to fundamental value ($0.15)</li>
</ol>
<h3>Why It Happens</h3>
<ul>
<li>Low liquidity (few shares trading)</li>
<li>No real business (biotech startup with no product yet)</li>
<li>Promotional materials (newsletters, social media hype)</li>
<li>Insiders with information advantage</li>
<li>Retail traders with FOMO</li>
</ul>
<h3>How to Avoid</h3>
<ul>
<li>Avoid stocks under $2 (high risk)</li>
<li>Check trading volume (penny stocks have low volume)</li>
<li>Verify claims independently</li>
<li>Check insider ownership (if insiders own 90%, watch out)</li>
<li>Never trust "hot tips"</li>
</ul>
<hr>
<h2>Case Study 10: Iron Condor Options Strategy - Income Generation</h2>
<p><strong>Duration</strong>: 45 days (One complete options cycle)</p>
<p><strong>Initial Capital</strong>: $20,000 margin requirement</p>
<p><strong>Profit</strong>: +$3,000 (15% return on margin)</p>
<p><strong>Risk Management</strong>: Defined risk, disciplined exit</p>
<p><strong>Key Insight</strong>: Income generation has defined profit potential</p>
<h3>The Setup</h3>
<ul>
<li>SPY trading at $450</li>
<li>Sell $440 put (collect premium)</li>
<li>Buy $435 put (define risk)</li>
<li>Sell $460 call (collect premium)</li>
<li>Buy $465 call (define risk)</li>
<li>Total premium collected: $3.00/share</li>
</ul>
<h3>The Math</h3>
<div class="example-block">
  Max profit: $300 (premiums collected)<br>
  Max loss: $1,700 (width of strikes minus premium)<br>
  Required margin: $2,000<br>
  Return if max profit: 15%<br>
  Return if max loss: -85%<br>
  Probability of profit: 65-70%
</div>
<h3>Results</h3>
<ul>
<li>SPY didn't move significantly</li>
<li>Profit target reached early</li>
<li>Closed position for $300 profit</li>
<li>Success was discipline, not luck</li>
</ul>
<h3>When Iron Condor Fails</h3>
<ul>
<li>Wide market moves beyond strikes</li>
<li>Forced to take loss to prevent max loss</li>
<li>Assignment complexity</li>
<li>Low return relative to risk of holding</li>
</ul>
<hr>
<h2>Case Study 11: COVID Vaccine Winners and Losers - Timing Industry Tailwinds</h2>
<p><strong>Duration</strong>: 12 months (Vaccine development 2020-2021)</p>
<p><strong>Winners</strong>: Moderna (MRNA) +400%, BioNTech (BNTX) +300%</p>
<p><strong>Losers</strong>: Traditional pharma, tourism stocks</p>
<p><strong>Key Insight</strong>: Industry tailwinds create opportunities</p>
<h3>The Winners: Who Benefited</h3>
<ul>
<li>Vaccine makers: MRNA, BNTX, JNJ (vaccine division)</li>
<li>Diagnostic companies: DxCO, QIVRX</li>
<li>Testing companies: Multiple private companies</li>
<li>Telemedicine: TELADOC, AMMD</li>
</ul>
<h3>The Losers: Who Lost</h3>
<ul>
<li>Cruise lines: RCL, CCL (down 50-70%)</li>
<li>Airlines: DAL, UAL (down 30-50%)</li>
<li>Hotels: MAR, RLC (down temporarily)</li>
<li>Theaters: AMC, CMC (down 70%)</li>
</ul>
<h3>Lesson</h3>
<ul>
<li>Don't fight industry tailwinds (vaccine rollout was inevitable positive)</li>
<li>Industry tailwinds can drive 300%+ gains</li>
<li>But don't overestimate (MRNA up 400% in 1 year, not sustainable)</li>
<li>Timing exit is critical (MRNA down 70% from peak by 2022)</li>
</ul>
<hr>
<h2>Case Study 12: Short Selling Disaster - Unlimited Loss Potential</h2>
<p><strong>Duration</strong>: 4 months (January-April 2021)</p>
<p><strong>Trade</strong>: Shorted GameStop (GME) at $15/share</p>
<p><strong>Position</strong>: 100 shares short (borrowed to sell)</p>
<p><strong>Initial profit</strong>: Up to +$2,000 when GME fell to $5</p>
<p><strong>Peak loss</strong>: -$12,700 when GME rallied to $127</p>
<p><strong>Outcome</strong>: Forced to cover at $127, lost $12,000</p>
<p><strong>Return</strong>: -80% on $15,000 position</p>
<h3>What Went Wrong</h3>
<ol>
<li>Underestimated retail investor coordination</li>
<li>Didn't monitor short interest (extremely high)</li>
<li>Didn't have stop loss (or ignored it)</li>
<li>Didn't understand short squeeze mechanics</li>
</ol>
<h3>The Short Squeeze</h3>
<div class="example-block">
  Heavily shorted stock: 140% of float short (more shares shorted than exist!)<br>
  Retail investors buy: GME price rises<br>
  Short sellers panic cover: Buy back shares (more demand)<br>
  Price rises faster: Infinity squeeze potential<br>
  Short seller loss: Unlimited (no maximum price)
</div>
<h3>The Lesson</h3>
<p>Never short if:</p>
<ul>
<li>Short interest > 30% of float</li>
<li>Stock heavily promoted on social media</li>
<li>You don't have perfect stop loss discipline</li>
<li>You can't afford margin calls</li>
</ul>
<p>Short selling risk is asymmetric: Can lose unlimited, profit is capped at 100%.</p>
<hr>
<h2>Case Study 13: Chasing Yesterday's Winners - Recency Bias Cost 35%</h2>
<p><strong>Duration</strong>: 6 months (August 2022 - February 2023)</p>
<p><strong>Initial Position</strong>: $50,000 in index funds</p>
<p><strong>Mistake</strong>: Chased ARKK (growth funds) after they outperformed</p>
<p><strong>Entry</strong>: Bought ARKK at peak ($65/share)</p>
<p><strong>Exit</strong>: Sold at $42/share after 35% loss</p>
<p><strong>Lesson</strong>: The best performing funds in past year often underperform next year</p>
<h3>The Psychology</h3>
<ol>
<li>See ARKK up 80% in 2020-2021</li>
<li>Feel FOMO: "I'm missing the rally"</li>
<li>Buy in August 2022 (right at the top)</li>
<li>Stock falls 35% in next 6 months</li>
<li>Panic sell at the bottom</li>
</ol>
<h3>Why This Happens</h3>
<ul>
<li>Past winners become overvalued</li>
<li>Growth slows as size increases</li>
<li>Mean reversion is real</li>
<li>Recency bias makes recent winners seem safer</li>
</ul>
<h3>The Data</h3>
<p>Top 10 fund performers in 2021 were bottom 10 in 2022. Perfectly inverted returns.</p>
<h3>Lesson</h3>
<ul>
<li>Buy winners (ARKK was great in 2020)</li>
<li>But buy them at reasonable valuations</li>
<li>Don't buy them BECAUSE they recently won</li>
<li>Value traps are often yesterday's winners at new highs</li>
</ul>
<hr>
<h2>Case Study 14: Overleveraged Account Collapse - 6x Leverage, 80% Loss</h2>
<p><strong>Duration</strong>: 3 months until liquidation</p>
<p><strong>Starting Capital</strong>: $50,000</p>
<p><strong>Leverage Ratio</strong>: 6x ($300,000 total deployed)</p>
<p><strong>Margin Requirement</strong>: 30% ($90,000 minimum needed)</p>
<p><strong>Market Decline</strong>: -15% (normal correction)</p>
<p><strong>Impact</strong>: Account loses $45,000 (loses ALL margin buffer)</p>
<p><strong>Result</strong>: Forced liquidation of all positions at worst prices</p>
<h3>The Math</h3>
<div class="example-block">
  Capital: $50,000<br>
  Margin borrowed: $250,000<br>
  Total invested: $300,000<br>
  Margin requirement: 30% = $90,000 required<br><br>
  After 15% decline:<br>
  Portfolio value: $255,000<br>
  Margin requirement still: $90,000<br>
  Available equity: $165,000 (still fine)<br><br>
  But broker uses dynamic margin:<br>
  Margin required for $250,000 borrowed: 25% = $62,500<br>
  Margin required + positions: $255,000 √ó 30% = $76,500<br>
  Available: Only $49,500<br>
  Margin call!<br><br>
  Forced to sell $50,000 of positions in falling market<br>
  Selling creates more losses<br>
  Spiral continues until account liquidated
</div>
<h3>The Lesson</h3>
<p>Leverage amplifies BOTH gains and losses:</p>
<ul>
<li>1x leverage: 15% loss = -15% on account</li>
<li>2x leverage: 15% loss = -30% on account</li>
<li>6x leverage: 15% loss = -90% on account</li>
</ul>
<p>For most traders, leverage is a guaranteed way to go broke.</p>
<hr>
<h2>Case Study 15: The Diversification Lesson - Concentrated Portfolio vs Diversified</h2>
<p><strong>Duration</strong>: 5-year comparison (2019-2024)</p>
<p><strong>Scenario A - Concentrated</strong>: $100,000 in single stock (Tesla)</p>
<p><strong>Scenario B - Diversified</strong>: $100,000 in 20 stocks</p>
<h3>The Results</h3>
<p><strong>Concentrated (All Tesla)</strong></p>
<ul>
<li>2019: +30%</li>
<li>2020: +700%</li>
<li>2021: +50%</li>
<li>2022: -65%</li>
<li>2023: +100%</li>
<li>2024: +30%</li>
<li>Ending value: $280,000</li>
<li>Total return: +180%</li>
<li>Best year: +700%</li>
<li>Worst year: -65%</li>
<li>Volatility: 67% annual standard deviation</li>
</ul>
<p><strong>Diversified (20 stocks)</strong></p>
<ul>
<li>Average annual return: +12%</li>
<li>Ending value: $176,000</li>
<li>Total return: +95%</li>
<li>Best year: +25%</li>
<li>Worst year: -15%</li>
<li>Volatility: 18% annual standard deviation</li>
</ul>
<h3>The Comparison</h3>
<table>
    <thead>
        <tr>
            <th>Metric</th>
            <th>Concentrated</th>
            <th>Diversified</th>
            <th>Winner</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td>Total return</td>
            <td>+180%</td>
            <td>+95%</td>
            <td>Concentrated</td>
        </tr>
        <tr>
            <td>Annual volatility</td>
            <td>67%</td>
            <td>18%</td>
            <td>Diversified</td>
        </tr>
        <tr>
            <td>Best year</td>
            <td>+700%</td>
            <td>+25%</td>
            <td>Concentrated</td>
        </tr>
        <tr>
            <td>Worst year</td>
            <td>-65%</td>
            <td>-15%</td>
            <td>Diversified</td>
        </tr>
        <tr>
            <td>Drawdown</td>
            <td>-73%</td>
            <td>-18%</td>
            <td>Diversified</td>
        </tr>
        <tr>
            <td>Sleep quality</td>
            <td>Poor</td>
            <td>Great</td>
            <td>Diversified</td>
        </tr>
    </tbody>
</table>
<h3>The Lesson</h3>
<p><strong>Concentrated portfolio</strong>:</p>
<ul>
<li>Higher returns (if you pick right)</li>
<li>Much higher stress</li>
<li>Emotional decision-making likely</li>
<li>One bad decision ruins years of gains</li>
<li>95% lose money concentrated</li>
</ul>
<p><strong>Diversified portfolio</strong>:</p>
<ul>
<li>Lower returns</li>
<li>Better sleep</li>
<li>Forced discipline</li>
<li>Survive bad decisions</li>
<li>70% make money diversified</li>
</ul>
<h3>The Real Lesson</h3>
<p>Most people think: "I want concentrated returns!"</p>
<p>But most people actually need: "I want to sleep at night and retire without stress"</p>
<p>Diversification is underrated because it's boring, but boredom is actually the goal.</p>
<hr>
<h2>Summary: What These 9 Cases Teach</h2>
<p>| Case | Outcome | Main Lesson |</p>
<p>|---|---|---|</p>
<p>| 07 - Sector Rotation | +48% | Industry momentum can be traded |</p>
<p>| 08 - Liquidation Hold | -80% | Know when to cut losses |</p>
<p>| 09 - Penny Stocks | -81% | Avoid penny stock traps |</p>
<p>| 10 - Iron Condor | +15% | Income strategies have limits |</p>
<p>| 11 - Vaccine Winners | +300% | Ride industry tailwinds |</p>
<p>| 12 - Short Selling | -80% | Never short without discipline |</p>
<p>| 13 - Chasing Winners | -35% | Recency bias kills |</p>
<p>| 14 - Overleveraged | -100% | Leverage destroys accounts |</p>
<p>| 15 - Diversification | +95% | Boring beats exciting |</p>
<p><strong>Meta-lesson</strong>: Out of these 9 additional cases, 4 were losses (08, 09, 12, 13), 1 was mediocre (10), and 4 were wins (07, 11, 14 prevented by diversification, 15).</p>
<p>The investors who survived and built wealth followed diversified, disciplined approaches. The ones who didn't were concentrated, emotional, and undisciplined.</p>
<hr>

                <div class="lesson-checkbox">
                    <input type="checkbox" id="lessonComplete">
                    <label for="lessonComplete">Mark this lesson as complete</label>
                </div>
            </article>

            <div class="lesson-navigation">
                <a href="case-study-06-dividend-aristocrats.html" class="nav-btn">‚Üê Previous Lesson</a>
                <a href="../index.html" class="nav-btn" style="background: var(--accent-secondary);">Back to Home</a>
                <a href="coaching-guides.html" class="nav-btn">Next Lesson ‚Üí</a>
            </div>
        </main>
    </div>

    <footer>
        <p>&copy; 2026 Stock Trading Mastery Course | Educational Content Only</p>
    </footer>

    <script src="../js/app.js"></script>
</body>
</html>